Recombinant Marek's disease virus type 1 provides full protection against H9N2 influenza A virus in chickens

文献类型： 外文期刊

第一作者： Chen, Yuntong

作者： Chen, Yuntong;Yu, Qingqing;Fan, Wenrui;Zeng, Xianying;Zhang, Zibo;Tian, Guobin;Liu, Changjun;Bao, Hongmei;Wu, Longbo;Zhang, Yanping;Liu, Yongzhen;Wang, Suyan;Cui, Hongyu;Duan, Yulu;Chen, Hualan;Gao, Yulong

作者机构：

关键词： Marek's disease virus; MDV1 vaccine strain; Hemagglutinin protein; Protective efficacy

期刊名称：VETERINARY MICROBIOLOGY （ 影响因子：2.7； 五年影响因子：2.9 ）

ISSN： 0378-1135

年卷期： 2024 年 298 卷

页码：

收录情况： SCI

摘要： The H9N2 subtype of the avian influenza virus (AIV) poses a significant threat to the poultry industry and human health. Recombinant vaccines are the preferred method of controlling H9N2 AIV, and Marek's disease virus (MDV) is the ideal vector for recombinant vaccines. During this study, we constructed two recombinant MDV type 1 strains that carry the hemagglutinin (HA) gene of AIV to provide dual protection against both AIV and MDV. To assess the effects of different MDV insertion sites on the protective efficacy of H9N2 AIV, the HA gene of H9N2 AIV was inserted in UL41 and US2 of the MDV type 1 vector backbone to obtain recombinant viruses rMDV-UL41/HA and rMDV-US2/HA, respectively. An indirect immunofluorescence assay showed sustained expression of HA protein in both recombinant viruses. Additionally, the insertion of the HA gene in UL41 and US2 did not affect MDV replication in cell cultures. After immunization of specific pathogen-free chickens, although both the rMDV-UL41/HA and rMDV-US2/HA groups exhibited similar levels of hemagglutination inhibition antibody titers, only the rMDV-UL41/HA group provided complete protection against the H9N2 AIV challenge, and also offered complete protection against challenge with MDV. These results demonstrated that rMDV-UL41/HA could be used as a promising bivalent vaccine strain against both H9N2 avian influenza and Marek's disease in chickens.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序